Title: Immunotherapy Side Effect Management: New Evidence for Medicinal Mushroom Extracts in Lung Cancer Care
Meta Description: Manage immunotherapy side effects with medicinal mushroom extracts based on new evidence. Blue Eyes Biotech offers standardized mushroom extracts for lung cancer support formulations.
Article:
While immune checkpoint inhibitors have revolutionized lung cancer treatment, their immune-related adverse events (irAEs) can significantly impact
patients' quality of life and sometimes lead to treatment discontinuation. A 2024 randomized controlled trial published in Supportive Care
in Cancer has provided compelling evidence that standardized medicinal mushroom extracts can effectively mitigate these side effects while
potentially enhancing treatment efficacy. The study found that patients receiving a combination of Coriolus versicolor and Ganoderma
lucidum extracts alongside pembrolizumab experienced significantly lower incidence and severity of common irAEs, including rash, diarrhea,
and fatigue. The researchers attributed these benefits to the beta-glucans and other bioactive compounds in mushrooms, which help
modulate immune response rather than simply stimulating it, promoting a more balanced immunological environment. Blue Eyes Biotech CO., Ltd.
supports this emerging application of medicinal mushrooms through our portfolio of highly characterized fungal extracts. Our Coriolus
versicolor extract is standardized to contain 40% polysaccharides and 25% beta-glucans, while our Ganoderma lucidum extract is
standardized for triterpenes and polysaccharides, ensuring consistent biological activity. For supplement companies developing supportive
care products for lung cancer patients undergoing immunotherapy, the standardization and purity of mushroom ingredients are essential.
Blue Eyes Biotech employs sophisticated extraction methods that preserve the delicate immunological compounds while eliminating
potentially harmful contaminants. Each batch is tested for heavy metals, pesticides, and microbial contaminants to ensure patient safety.
Our technical documentation includes information on optimal dosing and potential synergistic effects between different mushroom species.
By formulating with our standardized medicinal mushroom extracts, nutraceutical brands can create scientifically-validated products that
help manage immunotherapy side effects, potentially improving treatment adherence and quality of life for lung cancer patients.
For a consultation on our medicinal mushroom portfolio, email [email protected].